![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Real-world effectiveness of sofosbuvir/velpatasvir/voxilaprevir as a
hepatitis C virus infection salvage treatment
|
|
|
AASLD 2019 Nov 8-12 Boston
Reported by Jules Levin
Mel Krajden1,2, Darrel Cook1, Stanley Wong1,2, James Wilton1, Zahid A Butt1,3, Sofia Barlett1,2, Margo Pearce1,2, Alnoor Ramji2, Eric M. Yoshida2, Amanda Yu1, Maria Alvarez1, Mawuena Binka1, Naveed Z. Janjua1,2
1 BC Centre for Disease Control, Vancouver, BC; 2 University of British Columbia, Vancouver, BC, Canada; 3 University of Waterloo, Ontario
![1114191](../images/111519/111419-12/1114191.gif)
![1114192](../images/111519/111419-12/1114192.gif)
![1114193](../images/111519/111419-12/1114193.gif)
![1114194](../images/111519/111419-12/1114194.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|